Skip to main content

Published locations for IL-22 blocker investigated in phase 2a atopic dermatitis study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. IL-22 blocker investigated in phase 2a atopic dermatitis study

User login

  • Reset your password
  • /content/il-22-blocker-investigated-phase-2a-atopic-dermatitis-study
  • /edermatologynews/article/164279/atopic-dermatitis/il-22-blocker-investigated-phase-2a-atopic
  • /familypracticenews/article/164279/atopic-dermatitis/il-22-blocker-investigated-phase-2a-atopic
  • /internalmedicinenews/article/164279/atopic-dermatitis/il-22-blocker-investigated-phase-2a-atopic
  • /internalmedicine/article/164279/atopic-dermatitis/il-22-blocker-investigated-phase-2a-atopic
  • /dermatology/article/164279/atopic-dermatitis/il-22-blocker-investigated-phase-2a-atopic-dermatitis
  • /familymedicine/article/164279/atopic-dermatitis/il-22-blocker-investigated-phase-2a-atopic